Megan Boston - Aug 11, 2023 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role: Executive Director, Director
Signature: /s/ Megan Boston
Stock symbol: BNTC
Transactions as of: Aug 11, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/14/2023, 05:13 PM
Previous filing: Jun 15, 2023
Next filing: Mar 8, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNTC	Common Stock	Purchase		+25.9K			25.9K	Aug 11, 2023	Direct	F1
holding	BNTC	Common Stock						20	Aug 11, 2023	By Boston Super Invest Pty A/C Boston Family Super	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNTC	Common Warrants (right to buy)	Purchase		+25.9K			25.9K	Aug 11, 2023	Common Stock	25.9K	$3.86	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock, par value $0.0001 per share (the "Common Stock") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93.
F2	The reported number of shares has been adjusted to reflect the impact of the Issuer's 17-for-1 reverse stock split completed on July 26, 2023.